mim-tRNAseq vs Nanopore for tRNA expression, modification, and charging profiling

Selecting the appropriate platform is critical for accurate tRNA abundance/modification/charging profiling. While direct Nanopore sequencing enables native RNA characterization, mim-tRNA-seq leverages high-accuracy Illumina sequencing and optimized tRNA-specific workflows for robust quantitative analysis. The comparison below outlines the major differences between the two technologies across key performance metrics to help researchers choose the most suitable solution.

 

 

Arraystar mim-tRNA-seq (Illumina/TGIRT)

Direct Nanopore tRNA Sequencing

tRNA optimization

Specifically optimized for tRNA profiling

Native tRNA sequencing workflows are still evolving

Sequencing principle

Reverse transcription + Illumina sequencing

Direct sequencing of native RNA

Read accuracy

>99.9% Illumina accuracy

Lower raw read accuracy; continually improving

tRNA mapping accuracy

High-confidence mapping enabled by high-accuracy Illumina reads and mature tRNA-specific algorithms

Mapping accuracy is affected by short tRNA length, lower Q-scores, and modification-induced basecalling errors

tRNA abundance

Deep sequencing with mature mapping for robust quantification

Quantification depends on sequencing yield and bioinformatics

tRNA modification

Established RT-signature analysis with mature statistical framework

Native signal-based detection; computational interpretation still evolving

tRNA charging

Chemically optimized for quantitative charging analysis

Quantitative charging workflows are still emerging

Statistical comparison

Optimized for quantitative comparison across biological groups

Comparative analysis depends on specialized computational workflows

Bioinformatics

Standardized pipeline with publication-ready results

Specialized signal analysis and custom workflows

Key strengths

Quantitative profiling of abundance, charging, and RT-sensitive modifications

Native RNA sequencing with single-molecule resolution

Best applications

Comparative biology, disease studies, biomarker discovery

Native RNA characterization and method development